INVESTOR DISCLAIMER

*Select your investor type

Terms and Conditions

These terms and conditions govern your use of this website (http://www.investlinx-etf.com). By accessing this website, you agree that you have read and accept these terms and conditions, including our “Cookies Notice”. If you do not wish to be bound by these terms and conditions, please leave this website.

The products referred to on this website are sub-funds of INVESTLINX ICAV (the “ICAV”), registered in Ireland with registration number C494926 and authorised and regulated by the Central Bank of Ireland as a UCITS. The ICAV is managed by Investlinx Investment Management Limited (“INVESTLINX”), an investment management company regulated by the Central Bank of Ireland and registered in Ireland with registration number 703761. INVESTLINX is also authorised to provide investment advisory services and discretionary portfolio management services to professional investors.

By proceeding, please note that the information provided by this website is only for Italian Private Investors, for Irish Private Investors and for Professional Investors in the European Economic Area (EEA).

Access to information displayed on this website may be restricted to certain persons in certain countries. INVESTLINX does not intend information concerning products described on this website to be shown to any persons and/or entities who are prohibited from seeing such information by their country of residence, domicile and/or incorporation (as applicable). Users of this website must ensure that they are legally permitted to access this website in the country where they do so. Users are also responsible for ensuring that their declarations regarding their countries of residence, domicile and/or incorporation when accessing this website are accurate.

The information in this website should not be considered as an offer or solicitation to buy or sell securities. The website, or any document referred to in this website, is not intended to contain and should not be regarded as containing advice relating to legal, taxation, investment or any other matters. The website may not be adequate for the needs, profile and experience of each individual investor. Each prospective investor should consult with their own professional advisers as to any legal, economic, or tax implications and related aspects which may be relevant to the purchase, holding or disposal of shares in one or more sub-funds of the ICAV and as to suitability of an investment for such investor. The levels and bases of taxation are dependent on individual circumstances and subject to change and therefore it is highly recommended that you consult a professional tax advisor.


This is a marketing communication. You should seek professional investment advice before making any decision to invest. Investment in shares of any sub-fund of the ICAV is subject to risks. The Investors are recommended to read carefully the Prospectus, Supplements, the KID and the annual financial statement of the ICAV and its sub-funds before investing.


Performance information: The performance figures quoted on this website refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. The value of Shares may go down as well as up, and investors may not get back any of the amount invested. The value of investments involves exposure to foreign currencies and may therefore be affected by exchange rate movements. An investment in shares of any sub-fund of the ICAV should only be made by persons who can sustain a loss on their investment. Any such investment should not constitute a substantial portion of an investment portfolio and may not be appropriate for all investors. Your investment may also be subject to currency, interest rate, as well as market fluctuations. Specific risk warnings are set out in the prospectus and if applicable the supplement for the relevant product.


Information and opinions contained in this website have been compiled from sources believed to be reliable but INVESTLINX does not make any representations as to its accuracy or completeness. Any opinions, forecasts or estimates herein constitute a judgement that is subject to change without notice. Any reference to individual investments should not be taken as a recommendation to buy or sell. INVESTLINX disclaims all liability and responsibility arising from any reliance placed by any user of this website, or by anyone who may be informed of any of the information on this website, on materials and information posted on this website.


No part of (or information contained on) this website may be reproduced, distributed or transmitted without the prior written permission of INVESTLINX.

INVESTLINX will not be liable for any loss or damage arising out of or in connection with the use of this site.


Data protection


See the INVESTLINX
Privacy Statement relating to the collection and use of your personal information. Personal information provided by you will be held in confidence by INVESTLINX and will not be passed on by INVESTLINX to other product or service companies except as permitted by the important information or the INVESTLINX Privacy Statement.


Cookies Notice


INVESTLINX may obtain information about your general internet usage by using a cookie file which is stored on the hard drive of your computer, for the purposes of systems administration and statistical analysis. Cookies contain information that is transferred to your computer’s hard drive and help INVESTLINX to improve this Website and to deliver a better and more personalised service to you, including by storing information about your preferences and to recognise you when you return to this Website. You may refuse to accept cookies by activating the setting on your browser which allows you to refuse the setting of cookies. However, if you select this setting you may be unable to access certain parts of this Website. Unless you have adjusted your browser setting so that it will refuse cookies, INVESTLINX’ system will issue cookies when you log on to this Website.

Variation

INVESTLINX reserves the right to vary these terms and conditions from time to time. You can access the latest version of the terms and conditions on this website.


Governing Law and Jurisdiction

These terms and conditions and your access to and use of this website and the content are subject to Irish law and the jurisdiction of the Irish courts. If any provision of these terms and conditions in judicial proceedings is held illegal or unenforceable, such provision shall be severed and shall be inoperative, and the remainder of these terms and conditions shall remain operative, in full force and effect and binding on you.

Terms and Conditions

These terms and conditions govern your use of this website (http://www.investlinx-etf.com). By accessing this website, you agree that you have read and accept these terms and conditions, including our “Cookies Notice”. If you do not wish to be bound by these terms and conditions, please leave this website.

The products referred to on this website are sub-funds of INVESTLINX ICAV (the “ICAV”), registered in Ireland with registration number C494926 and authorised and regulated by the Central Bank of Ireland as a UCITS. The ICAV is managed by Investlinx Investment Management Limited (“INVESTLINX”), an investment management company regulated by the Central Bank of Ireland and registered in Ireland with registration number 703761. INVESTLINX is also authorised to provide investment advisory services and discretionary portfolio management services to professional investors.


By proceeding, please note that the information provided by this website is only for Italian Private Investors, for Irish Private Investors and for Professional Investors in the European Economic Area (EEA).


Access to information displayed on this website may be restricted to certain persons in certain countries. INVESTLINX does not intend information concerning products described on this website to be shown to any persons and/or entities who are prohibited from seeing such information by their country of residence, domicile and/or incorporation (as applicable). Users of this website must ensure that they are legally permitted to access this website in the country where they do so. Users are also responsible for ensuring that their declarations regarding their countries of residence, domicile and/or incorporation when accessing this website are accurate.


The information in this website should not be considered as an offer or solicitation to buy or sell securities. The website, or any document referred to in this website, is not intended to contain and should not be regarded as containing advice relating to legal, taxation, investment or any other matters. The website may not be adequate for the needs, profile and experience of each individual investor. Each prospective investor should consult with their own professional advisers as to any legal, economic, or tax implications and related aspects which may be relevant to the purchase, holding or disposal of shares in one or more sub-funds of the ICAV and as to suitability of an investment for such investor. The levels and bases of taxation are dependent on individual circumstances and subject to change and therefore it is highly recommended that you consult a professional tax advisor.


This is a marketing communication. You should seek professional investment advice before making any decision to invest. Investment in shares of any sub-fund of the ICAV is subject to risks. The Investors are recommended to read carefully the Prospectus, Supplements, the KID and the annual financial statement of the ICAV and its sub-funds before investing.


Performance information: The performance figures quoted on this website refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. The value of Shares may go down as well as up, and investors may not get back any of the amount invested. The value of investments involves exposure to foreign currencies and may therefore be affected by exchange rate movements. An investment in shares of any sub-fund of the ICAV should only be made by persons who can sustain a loss on their investment. Any such investment should not constitute a substantial portion of an investment portfolio and may not be appropriate for all investors. Your investment may also be subject to currency, interest rate, as well as market fluctuations. Specific risk warnings are set out in the prospectus and if applicable the supplement for the relevant product.


Information and opinions contained in this website have been compiled from sources believed to be reliable but INVESTLINX does not make any representations as to its accuracy or completeness. Any opinions, forecasts or estimates herein constitute a judgement that is subject to change without notice. Any reference to individual investments should not be taken as a recommendation to buy or sell. INVESTLINX disclaims all liability and responsibility arising from any reliance placed by any user of this website, or by anyone who may be informed of any of the information on this website, on materials and information posted on this website.

No part of (or information contained on) this website may be reproduced, distributed or transmitted without the prior written permission of INVESTLINX.
INVESTLINX will not be liable for any loss or damage arising out of or in connection with the use of this site.


Data protection

See the INVESTLINX Privacy Statement relating to the collection and use of your personal information. Personal information provided by you will be held in confidence by INVESTLINX and will not be passed on by INVESTLINX to other product or service companies except as permitted by the important information or the INVESTLINX Privacy Statement.

Cookies Notice

INVESTLINX may obtain information about your general internet usage by using a cookie file which is stored on the hard drive of your computer, for the purposes of systems administration and statistical analysis. Cookies contain information that is transferred to your computer’s hard drive and help INVESTLINX to improve this Website and to deliver a better and more personalised service to you, including by storing information about your preferences and to recognise you when you return to this Website. You may refuse to accept cookies by activating the setting on your browser which allows you to refuse the setting of cookies. However, if you select this setting you may be unable to access certain parts of this Website. Unless you have adjusted your browser setting so that it will refuse cookies, INVESTLINX’ system will issue cookies when you log on to this Website.
Variation

INVESTLINX reserves the right to vary these terms and conditions from time to time. You can access the latest version of the terms and conditions on this website.



Governing Law and Jurisdiction


These terms and conditions and your access to and use of this website and the content are subject to Irish law and the jurisdiction of the Irish courts. If any provision of these terms and conditions in judicial proceedings is held illegal or unenforceable, such provision shall be severed and shall be inoperative, and the remainder of these terms and conditions shall remain operative, in full force and effect and binding on you.

This website is under maintenance and none of the information is to be taken as accurate.

Portfolio Managers’ View on Emerging Competition From China to ASML

Since the launch of our ETFs, we have been shareholders of ASML, reflecting our conviction in the company’s dominant competitive position, substantial barriers to entry, and strong long-term structural growth drivers. ASML is the leading manufacturer and supplier of lithography systems used in semiconductor chip production and occupies a uniquely strong position as the sole supplier of extreme ultraviolet (EUV) lithography machines. These systems are essential for the manufacture of the most advanced semiconductor chips, with demand supported by continued growth in artificial intelligence.

Recent Developments in Competitive Dynamics

This week, Reuters reported that China developed a prototype EUV lithography tool in early 2025 and has since entered a testing phase. The report indicates that this effort involves former ASML engineers and the reverse engineering of ASML’s EUV technology. According to Reuters, the prototype is operational and capable of generating extreme ultraviolet light; however, it has not yet been used to manufacture functional semiconductor chips. The article states that the Chinese government is targeting working chips by 2028.

Based on our discussions and preliminary research, we believe a more realistic timeline extends beyond 2030. While we acknowledge that this situation will continue to evolve, our assessment is grounded in currently available public information. In our initial assessment, China’s current prototype appears more comparable to ASML’s early development stage in 2001, when the company achieved its first internally developed working EUV prototype. For context, ASML required approximately five years to deliver its first external alpha demonstration tool in 2006, followed by a further four years to ship its first production-class system in 2010. Notably, the first EUV tool suitable for high-volume manufacturing was not delivered until 2017.

Reassessment of ASML Following the Recent News

While the Reuters article is likely to be headline-grabbing, we believe it risks overstating the near-term competitive threat and underestimating the broader context. As outlined above, the short- to medium-term risk to ASML’s market position appears manageable, given the historically long timelines required to progress from prototype development to a commercially viable, high-volume manufacturing tool, as demonstrated by ASML’s own experience. It is important to acknowledge that China’s development efforts could advance more rapidly due to reverse engineering. However, even under an accelerated scenario, we believe this would remain outside our investment time horizon, thereby continuing to support ASML’s dominant market position.

Over the longer term, increased competition is possible should Chinese firms successfully commercialize EUV technology. That said, the implications are not necessarily negative for ASML. Currently, ASML is unable to ship EUV systems to China due to export restrictions. There is a credible argument that successful domestic EUV development in China could eventually prompt the U.S. and EU to ease these restrictions, potentially allowing ASML to sell into the Chinese market and expand its total addressable market (TAM). Given the early stage of China’s EUV development, we assess near-term financial risk as limited, as ASML does not sell EUV systems into China due to existing Western export restrictions.

We will continue to closely monitor developments related to competitive dynamics. Overall, we remain comfortable with ASML’s positioning within the expected holding period of the funds. It is also worth noting that a production-grade EUV system requires not only the ability to generate EUV light, but also exceptional image fidelity, overlay accuracy, throughput, and tool availability. Achieving these performance characteristics to replicate an ASML-like high-volume manufacturing environment typically requires many years of refinement beyond the prototype stage.

Valuation and Investment Outlook

From a valuation perspective, the stock currently trades on a blended forward P/E multiple of 33.8x, compared with its historical 5-year average of 33.5x. Based on our assumptions, we believe the stock has the potential to deliver a 25+% cumulative return over the next three years.

We also see potential for additional upside supported by several factors, including a strengthening memory upcycle, potential incremental orders from Intel, a recovery in non-AI-related end markets, and the adoption of High NA lithography systems. The latter, in particular, is expected to drive both higher revenue growth and margin expansion over time.

Overall, we believe ASML’s unique and strategically critical position within the semiconductor value chain supports its status as a core holding within our semiconductor allocation. Alongside investments in TSMC and Cadence, this positioning ensures diversified exposure to key segments of the semiconductor ecosystem.

No Document

Subscribe to our newsletter

JOIN OUR MAILING LIST

Subscribe to our Mailing list to get the latest news and updates

This is a marketing communication.

Please refer to the Prospectus of the UCITS and to the KID before making any final investment decisions.